Hofseth BioCare ASA (HOFBF)
USD 0.16
(0.0%)
USD 0.16
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 194.87 Million | 12.12 Million | 8.7 Million | 6.13 Million | 7.71 Million | 60.74 Million |
| Cost of Revenue | 164.99 Million | 18.28 Million | 15.69 Million | 12.37 Million | 12.1 Million | 59.27 Million |
| Gross Profit | 29.87 Million | -6.16 Million | -6.98 Million | -6.24 Million | -4.39 Million | 1.46 Million |
| Operating Expenses | 156.04 Million | 6.94 Million | 7.98 Million | 6.46 Million | 4.81 Million | 82.36 Million |
| Selling, General and Administrative Expenses | 65.48 Million | 7.1 Million | 6.56 Million | 5.22 Million | 3.52 Million | 42.81 Million |
| Research and Development Expenses | 11.01 Million | 13.63 Million | 1.41 Million | 1.22 Million | 276.87 Thousand | 9.86 Million |
| Other Expenses | 59.08 Million | 158.83 Thousand | - | -10.04 Thousand | -1.01 Million | - |
| Cost and Expenses | 297.4 Million | 25.23 Million | 23.67 Million | 18.84 Million | 16.92 Million | 141.64 Million |
| Operating Income | -102.52 Million | -13.11 Million | -14.97 Million | -12.71 Million | -9.21 Million | -77.69 Million |
| Interest Expense | 7.54 Million | 1 Million | 1.31 Million | 1.07 Million | 975.72 Thousand | 3.83 Million |
| Income Tax Expense | - | -66.57 Thousand | -73.05 Thousand | 26.86 Thousand | -59.06 Thousand | 249 Thousand |
| Earnings before Tax | -106.68 Million | -13.98 Million | -14.32 Million | -11.83 Million | -10.15 Million | -84.52 Million |
| Net Income | -106.68 Million | -13.98 Million | -14.32 Million | -11.92 Million | -10.15 Million | -84.76 Million |
| Earnings Per Share Basic | -0.27 | -0.04 | -0.04 | -0.04 | -0.03 | -0.33 |
| Earnings Per Share Diluted | -0.27 | -0.04 | -0.04 | -0.04 | -0.03 | -0.33 |
| Weighted Average Shares Outstanding | 395.08 Million | 374.73 Million | 357.83 Million | 333.65 Million | 307.29 Million | 256.87 Million |
| Weighted Average Shares Outstanding (Diluted) | 395.08 Million | 374.73 Million | 357.83 Million | 333.65 Million | 307.29 Million | 258.09 Million |
| Gross Margin | 0.15 | -0.51 | -0.80 | -1.02 | -0.57 | 0.02 |
| EBIT Margin | -0.36 | -0.83 | -1.34 | -1.62 | -0.82 | -0.95 |
| Profit Margin | -0.55 | -1.15 | -1.64 | -1.94 | -1.32 | -1.40 |
| EBITDA | -70.6 Million | -97.02 Million | -87.72 Million | -66.11 Million | -61.65 Million | -57.5 Million |
| Earnings Before Tax Margin | -0.53 | -1.08 | -1.72 | -2.07 | -1.19 | -1.28 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 6.75 Million | 4.81 Million | 4.5 Million | 194.87 Million | 4.63 Million | 4.72 Million |
| Cost of Revenue | 6.45 Million | 4.93 Million | 7.5 Million | 150.68 Million | 5.45 Million | 4.45 Million |
| Gross Profit | 303.1 Thousand | -122.61 Thousand | -2.99 Million | 44.18 Million | -817.79 Thousand | 266.05 Thousand |
| Operating Expenses | 2.15 Million | 2.29 Million | 1.84 Million | 170.35 Million | 1.64 Million | 1.67 Million |
| Selling, General and Administrative Expenses | 2.11 Million | 2.2 Million | 1.99 Million | - | 1.65 Million | 1.87 Million |
| Research and Development Expenses | 116.41 Thousand | 115.03 Thousand | 20.7 Million | - | 1.45 Million | 1.15 Million |
| Other Expenses | 81.69 Thousand | 24.11 Thousand | 150.99 Thousand | 398.49 Thousand | 10.64 Thousand | 201.84 Thousand |
| Cost and Expenses | 8.6 Million | 7.23 Million | 9.34 Million | 321.04 Million | 7.09 Million | 6.13 Million |
| Operating Income | -1.85 Million | -2.42 Million | -4.83 Million | -102.52 Million | -2.45 Million | -1.4 Million |
| Interest Expense | 3.63 Million | 3.27 Million | 427 Thousand | 7.54 Million | 209.07 Thousand | 409.27 Thousand |
| Income Tax Expense | 171.25 Thousand | 74.84 Thousand | 190.36 Thousand | -303.45 Thousand | -563.5 Thousand | -166.01 Thousand |
| Earnings before Tax | -1.47 Million | -2.6 Million | -4.85 Million | -106.68 Million | -2.59 Million | 536.3 Thousand |
| Net Income | -1.64 Million | -2.68 Million | -5.09 Million | -106.68 Million | -2.12 Million | 536.39 Thousand |
| Earnings Per Share Basic | -0.00 | -0.01 | -0.01 | - | -0.01 | 0.00 |
| Earnings Per Share Diluted | -0.00 | -0.01 | -0.01 | - | -0.01 | 0.00 |
| Weighted Average Shares Outstanding | 411.08 Million | 410.37 Million | 395.08 Million | 395.08 Million | 395.08 Million | 395.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 411.08 Million | 410.37 Million | 395.08 Million | 395.08 Million | 395.08 Million | 396.25 Million |
| Gross Margin | 0.04 | -0.03 | -0.67 | 0.23 | -0.18 | 0.06 |
| EBIT Margin | -0.16 | -0.34 | -0.87 | - | -0.35 | -0.10 |
| Profit Margin | -0.24 | -0.56 | -1.13 | -0.55 | -0.46 | 0.11 |
| EBITDA | -1.06 Million | -1.61 Million | -3.9 Million | - | -1.61 Million | -479.72 Thousand |
| Earnings Before Tax Margin | -0.27 | -0.50 | -1.07 | -0.53 | -0.53 | -0.30 |
ELRXF
ECRFF
MEDHLP
BIOCON
0JSP
NTRBW